中文 | English
Return
Total: 844 , 1/85
Show Home Prev Next End page: GO
MeSH:(Hepatitis B/drug therapy*)

2.Advances in new antivirals for chronic hepatitis B.

Yanhua TANG ; Hongyan LIANG ; Ge ZENG ; Sheng SHEN ; Jian SUN

Chinese Medical Journal 2022;135(5):571-583

4.Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022).

Hong YOU ; Ya Meng SUN ; Meng Yang ZHANG ; Yue Min NAN ; Xiao Yuan XU ; Tai Sheng LI ; Gui Qiang WANG ; Jin Lin HOU ; Zhongping DUAN ; Lai WEI ; Fu Sheng WANG ; Ji Dong JIA ; Hui ZHUANG

Chinese Journal of Hepatology 2023;31(4):385-388

5.Expert consensus on the clinical application of the markers of hepatitis B virus.

Chinese Journal of Hepatology 2023;31(4):389-400

6.The 2014 Hepatology Society of the Philippines consensus statements on the management of chronic hepatitis B.

Jamias Jade D. ; Balce-Santos Dulcinea A. ; Bocobo Joseph C. ; Labio Madalinee Eternity D. ; Lontok Ma. Antoinette DC. ; Macatula Therese C. ; Ong Janus P. ; Ong-Go Arlinking K. ; Wong Stephen ; Yu Ira I. ; Payawal Diana A.

Philippine Journal of Internal Medicine 2015;53(1):17-33

7.Mechanism and clinical significance of HBV reactivation after anti-HCV therapy.

Wan Jia ZENG ; Lin GAO ; Yi Wei XU ; Xiang Mei CHEN ; Fu Sheng WANG ; Feng Min LU

Chinese Journal of Hepatology 2022;30(9):997-1001

9.Reactivation of Hepatitis B Virus Following Systemic Chemotherapy for Malignant Lymphoma.

Seung Jun JANG ; Young Kul JUNG ; Hae Lim BAEK ; Hyun Hwa YOON ; Seung Kak SHIN ; Jun Shik HONG ; Jin Ny PARK ; Oh Sang KWON ; Yun Soo KIM ; Duck Joo CHOI ; Jae Hoon LEE ; Ju Hyun KIM

Korean Journal of Medicine 2013;85(6):598-603

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 844 , 1/85 Show Home Prev Next End page: GO